Revisiting monoamine oxidase inhibitors: A potential dual-action therapy for patients with prostate cancer and comorbid depression?

Abstract

The study focused on patients who underwent surgical or radiotherapy treatment and whose PSA level was steadily increasing before the intervention with the antidepressant phenelzine. There were no affective disorders among the study entry criteria, and androgen levels, as noted, were not elevated

Keywords

• receptor gene-expression
• glucocorticoid-receptor
• model
• phenelzine
• behaviors
• relevance
• anxiety
• mice